QIS 5 makes its mark

marking

The European Commission’s fifth quantitative impact study (QIS 5) on Solvency II, the new risk-based capital regime for European insurers due for implementation in November 2012, will run between August and mid-November this year. The exercise should be the last, and perhaps given the lessons of the financial crisis the most significant, opportunity for regulators and firms to assess how the Solvency II requirements will impact their firms and what their ultimate risk-based capital levels might

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: